Effect of Vitamin D3 Supplementation in Children From 12 to 30 Months of Age.
1 other identifier
interventional
220
1 country
1
Brief Summary
Background Vitamin D (VD) is essential for calcium absorption, bone health and growth in children. In a national representative sample authors found mean serum concentration of 25-Hydroxi-Vitamin-D (25-OH-D) of 59 nmol/L, in children \< 5 y of age. Prevalence deficiency of VD under 50 nmol/L was 33%, which means that 3 million preschool- age children have VD deficiency in Mexico. Additionally, less than 3% of the children use supplements with VD. Objective To assess the effect of 400UI, 800IU of vitamin D2 and 1000IU of vitamin D3-colecalciferol- over 25-Hidroxi Vitamin D (25-OH-D) status and a multiple vitamin supplementation per day as a control group in children from 12-30 months of age in Cuernavaca, Morelos in a 4 month period. Methods Randomized double blind parallel clinical trial, with vitamin D3 (colecalciferol) supplementation in 220 children from 12 - 30 months who attend day care centers. Three supplementations will be given to children: 400IU and 800IU of vitamin D2, the third group 1000IU of D3-colecalciferol- and the control group will receive a multi vitamin supplementation. The duration of the intervention will be 16 weeks. Blood measurements would be taken at baseline, and at 16 weeks. This study compares the efficacy of three dose of VD in children from 12-30 months of age, over the nutritional status of 25 hydroxivitamin D (25-OH-D). This intervention is of importance to establish supplementation strategies to prevent VD deficiency in Mexico. Keywords: Vitamin D, nutritional deficiencies, micronutrients, children, México.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2017
CompletedFirst Submitted
Initial submission to the registry
May 17, 2018
CompletedFirst Posted
Study publicly available on registry
June 4, 2018
CompletedJune 4, 2018
May 1, 2018
9 months
May 17, 2018
May 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Chanche in 400UI,of vitamin D2 over 25-Hidroxi Vitamin D
nmol/L
Measurements were taken at baseline, and at 16 weeks
Chanche in 800UI,of vitamin D2 over 25-Hidroxi Vitamin D
nmol/L
Measurements were taken at baseline, and at 16 weeks
Change in 1000 of vitamin D3 over 25-Hidroxi Vitamin D
nmol/L
Measurements were taken at baseline, and at 16 weeks
Study Arms (4)
400 IU/d vitamin D2
EXPERIMENTALChildren received 1mililiter (dosage applicator) containing 400 IU of vitamin D2 per day. This suplement also contained: iron, vitamin A, C, and E, folic acid, niacin and vitamins B1, B2, B6 y B12. Vitamin D2, dosage form (1 mililiter), frequency (daily) and duration 16 weeks
800 IU7d vitmin D2
EXPERIMENTALChildren received 2 mililiter (dosage applicator) containing 800 IU of vitamin D2 per day. This suplement also contained: iron, vitamin A, C, and E, folic acid, niacin and vitamins B1, B2, B6 y B12. Vitamin D2, dosage form (1 mililiter), frequency (daily) and duration 16 weeks
1000 IU vitamina D3
EXPERIMENTALChildren received 1drop (dosage applicator) containing 1000 IU of vitamin D3 per day. dosage form (1 drop), frequency (daily) and duration 16 weeks
Multiple vitamin
PLACEBO COMPARATORChildren received 1 mililiter of a supplement with multiple vitamins (dosage applicator) frequency (daily) and duration 16 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Children form 12-30 months of who attend the day care centers Children whose parents accepted their child to participate and sign the informed consent
You may not qualify if:
- Children receiving multiple micronutrient supplementation/ other vitamin D suplement
- Children whose parents did not accept to participate
- Children with capillary hemoglobin concentration \<9.0 g/dL at baseline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marta Rivera Pasquel
Cuernavaca, Morelos, 62100, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mario Flores, PhD
National Institute of Public Health, Mexico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The Moses Oakford method was used by an independent researcher to randomly assign each child to 1 of 3 groups to receive the administration of the three supplments. A computer was used to generate the random numbers (STATA v.13). Groups were stratified by age from 12- 18 months, from 19- 24 months and form 25- 30 months of age. Each block group was assigned 73 children.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Mario Flores-Aldana, MD, PhD Nutrition Surveillance, Director
Study Record Dates
First Submitted
May 17, 2018
First Posted
June 4, 2018
Study Start
September 15, 2016
Primary Completion
June 18, 2017
Study Completion
December 21, 2017
Last Updated
June 4, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share